William A. Boisvert to Hyperlipidemias
This is a "connection" page, showing publications William A. Boisvert has written about Hyperlipidemias.
Connection Strength
2.454
-
Cabrera-Fuentes HA, Boisvert WA. Refining the impact of early intermittent hyperlipidemia on atherosclerosis: Unveiling the role of neutrophil reprogramming, sex differences, gut microbiota, and maternal hypercholesterolemia. FASEB J. 2025 Mar 15; 39(5):e70425.
Score: 0.898
-
Baumer Y, McCurdy S, Weatherby TM, Mehta NN, Halbherr S, Halbherr P, Yamazaki N, Boisvert WA. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun. 2017 10 24; 8(1):1129.
Score: 0.538
-
McCurdy S, Baumer Y, Toulmin E, Lee BH, Boisvert WA. Macrophage-Specific Expression of IL-37 in Hyperlipidemic Mice Attenuates Atherosclerosis. J Immunol. 2017 11 15; 199(10):3604-3613.
Score: 0.537
-
Han X, Kitamoto S, Wang H, Boisvert WA. Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. FASEB J. 2010 Aug; 24(8):2869-80.
Score: 0.318
-
Baumer Y, Dey AK, Gutierrez-Huerta CA, Khalil NO, Sekine Y, Sanda GE, Zhuang J, Saxena A, Stempinski E, Elnabawi YA, Dagur PK, Ng Q, Teague HL, Keel A, Rodante JA, Boisvert WA, Tsoi LC, Gudjonsson JE, Bleck CKE, Chen MY, Bluemke DA, Gelfand JM, Schwartz DM, Kruth HS, Powell-Wiley TM, Playford MP, Mehta NN. Hyperlipidaemia and IFNgamma/TNFalpha Synergism are associated with cholesterol crystal formation in Endothelial cells partly through modulation of Lysosomal pH and Cholesterol homeostasis. EBioMedicine. 2020 Sep; 59:102876.
Score: 0.162